Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children

S. Khalilzadeh, M. R. Bloorsaz, N. Baghaie, S. Hakimi (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2007 - Congenital and acquired lung disorders: diagnostic and therapeutic indications in infants and children
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Khalilzadeh, M. R. Bloorsaz, N. Baghaie, S. Hakimi (Tehran, Islamic Republic Of Iran). Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children. Eur Respir J 2007; 30: Suppl. 51, 2381

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan
Source: Eur Respir J 2011; 37: 465
Year: 2011


LATE-BREAKING ABSTRACT: Clinical features common to five cases with secondary pulmonary alveolar proteinosis complicated with Behcet disease
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012


Clinical and radiological variants of fibrosis pulmonary sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



Clinical course and morphological signs of idiopathic pulmonary fibrosis and interstitial pneumonias
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004

Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre
Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way
Year: 2009


Occupational and environmental impact on the clinical course of autoimmune pulmonary alveolar proteinosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012

Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009


Possible ocular involvement in pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 28: 456
Year: 2006


Diagnostic value of radiographic findings with literature review in Chinese pulmonary alveolar proteinosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 744s
Year: 2006

Clinical characteristics of pulmonary alveolar microlithiasis in Japan
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage
Source: International Congress 2017 – Paediatric bronchology
Year: 2017

Alveolar proteinosis: epidemiology, possibilities of diagnosis
Source: Eur Respir J 2004; 24: Suppl. 48, 671s
Year: 2004

Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 215; 10.1183/20734735.0018-2020
Year: 2020



Radiological features of NTM pulmonary disease in patients with bronchiectasis
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010


Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005